Home » Topics » BioWorld Science

BioWorld Science
RSS

Glycoengineering improves the anti-inflammatory effects of small extracellular vesicles

May 31, 2022

NRG Therapeutics receives Biomedical Catalyst award for neurodegenerative disorders

May 31, 2022

Discovery of novel orally bioavailable SERD with enhanced pharmacological properties

May 31, 2022

Novel tricyclic HIV-1 integrase-LEDGF/p75 allosteric inhibitors show improved antiviral activity

May 31, 2022

Atux Iskay presents preclinical data on PP2A activator ATUX-792 in IPF

May 30, 2022

TrxR inhibitor Au-24 shows promise in vivo and in vitro for treating hepatocellular carcinoma

May 30, 2022

Morc2 S87L mutation in mice mimics human Charcot-Marie-Tooth disease

May 30, 2022

Broadenbio synthesizes new MAP4K1 inhibitors

May 30, 2022

Betta Pharmaceuticals identifies new IDH inhibitors

May 30, 2022

Tyligand Bioscience divulges GTPase KRAS mutant inhibitors

May 30, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...